Another day, another handful of potential healthcare and pharma watchdogs (not to mention a suggested to-do list). Apparently, the rumor that former Sen. Tom Daschle might take over at HHS was misguided; he's now said to be slated as the White House's own healthcare reform czar. Which raises the possibility--some might say fear--that HHS may be led by Rep. Rosa DeLauro of Connecticut. She's been a sometime critic of FDA and pharma, with a stated dislike of DTC ads, according to In Vivo. Plus, she decries shoddy foreign manufacturing and too-friendly relationships among industry and regulators.
As for FDA, here are some other names to put on that list of folks we're sure you're keeping:
Meanwhile, Eye on FDA is advancing a top three list of priorities for the incoming FDA leadership: Develop a road map for implementation of FDAAA; spell out just what makes a successful Risk Evaluation and Management Strategy; and come up with guidance on online marketing. What are yours?
- read the In Vivo article [2]
- check out the Eye on FDA to-do list [3]
Related Articles:
Who will take over at the FDA, HHS? [4]
Kindler: Take politics out of the FDA [5]
How will Obama change pharma? [6]
Med school fires ex-FDA commish [1]
Links:
[1] http://www.fiercepharma.com/story/med-school-fires-ex-fda-commish/2007-12-17
[2] http://invivoblog.blogspot.com/2008/11/new-administration-more-names-to.html
[3] http://www.eyeonfda.com/eye_on_fda/2008/11/more-unfinished.html
[4] http://www.fiercepharma.com/story/wholl-take-over-fda-and-hhs/2008-11-06?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FP0
[5] http://www.fiercepharma.com/story/kindler-take-politics-out-fda/2008-11-03
[6] http://www.fiercepharma.com/story/how-will-obama-change-pharma-world/2008-11-05